Edwards Lifesciences Corp

NYSE:EW   4:00:00 PM EDT
-0.15 (-0.21%)
: $70.20 +0.24 (+0.34%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)42.53B
Current PE30.64
Forward PE 27.44
2yr Forward PE 24.29
See more stats
Estimates Current Quarter
Revenue$1.48 Billion
Adjusted EPS$0.59
See more estimates
10-Day MA$70.88
50-Day MA$77.35
200-Day MA$81.45
See more pivots

Edwards Lifesciences Corp Stock, NYSE:EW

1 Edwards Way, Irvine, California 92614
United States of America
Phone: +1.949.250.2500
Number of Employees: 17300


Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.